Connection

John Kaczmar to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications John Kaczmar has written about Drug Resistance, Neoplasm.
John Kaczmar
Connection Strength
0.112
Drug Resistance, Neoplasm
  1. The efficacy of ceritinib in patients with ALK-positive non-small cell lung cancer. Ther Adv Respir Dis. 2015 Oct; 9(5):236-41.
    View in: PubMed
    Score: 0.112
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.